BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19417720)

  • 1. Drugs for MRSA with reduced susceptibility to vancomycin.
    Med Lett Drugs Ther; 2009 May; 51(1311):36; quiz 37. PubMed ID: 19417720
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
    Nannini E; Murray BE; Arias CA
    Curr Opin Pharmacol; 2010 Oct; 10(5):516-21. PubMed ID: 20598637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
    Twilla JD; Gelfand MS; Cleveland KO; Usery JB
    J Antimicrob Chemother; 2011 Nov; 66(11):2675-7. PubMed ID: 21831987
    [No Abstract]   [Full Text] [Related]  

  • 4. [Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].
    Grossi O; Talarmin JP; Boutoille D; Frioux R; Corvec S; Raffi F
    Med Mal Infect; 2008 Dec; 38 Spec No 2():10-2. PubMed ID: 19185203
    [No Abstract]   [Full Text] [Related]  

  • 5. Methicillin-resistant Staphylococcus aureus: the superbug.
    Ippolito G; Leone S; Lauria FN; Nicastri E; Wenzel RP
    Int J Infect Dis; 2010 Oct; 14 Suppl 4():S7-11. PubMed ID: 20851011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
    Vernadakis S; Saner FH; Rath PM; Kaiser GM; Mathe Z; Treckmann J; Paul A
    Transpl Infect Dis; 2009 Aug; 11(4):346-8. PubMed ID: 19497075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activity of telavancin and other antimicrobial agents against methicillin-resistant Staphylococcus aureus isolates collected from 1991 to 2006.
    Shams W; Walker ES; Levy F; Reynolds SA; Peterson SM; Sarubbi FA
    Chemotherapy; 2010; 56(5):411-6. PubMed ID: 20948212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vancomycin, what else?].
    Daurel C; Leclercq R
    Arch Pediatr; 2010 Sep; 17 Suppl 4():S121-8. PubMed ID: 20826319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates to vancomycin, teicoplanin, linezolide and daptomycin].
    Celikbilek N; Ozdem B; Gürelik FC; Güvenman S; Güner HR; Açıkgöz ZC
    Mikrobiyol Bul; 2011 Jul; 45(3):512-8. PubMed ID: 21935784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipopeptides and oxazolidinones--novel antibiotics in MRSA infection treatment].
    Pangercić A; Bukovski-Simonoski S; Barsić B
    Lijec Vjesn; 2010; 132 Suppl 1():11-3. PubMed ID: 20715711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Staphylococcus aureus and antibiotic resistance].
    Sancak B
    Mikrobiyol Bul; 2011 Jul; 45(3):565-76. PubMed ID: 21935792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
    Jørgen B; Merckoll P; Melby KK
    Scand J Infect Dis; 2007; 39(11-12):1059-62. PubMed ID: 17852934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical activity of anti-Gram-positive agents against methicillin-resistant Staphylococcus aureus.
    Gould IM
    J Antimicrob Chemother; 2011 May; 66 Suppl 4():iv17-iv21. PubMed ID: 21521703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of linezolid against clinical isolates of methicillin resistant Staphylococcus.
    Hannan A; Absar M; Usman M; Naeem T; Saleem S; Arshad M
    J Ayub Med Coll Abbottabad; 2009; 21(1):106-9. PubMed ID: 20364755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid resistance in coagulase-negative staphylococci.
    Kelly S; Collins J; Davin M; Gowing C; Murphy PG
    J Antimicrob Chemother; 2006 Oct; 58(4):898-9; author reply 899-900. PubMed ID: 16854956
    [No Abstract]   [Full Text] [Related]  

  • 16. [The cutting-edge of medicine anti-MRSA agents; how to select and how to use].
    Niki Y
    Nihon Naika Gakkai Zasshi; 2012 Apr; 101(4):1085-91. PubMed ID: 22730740
    [No Abstract]   [Full Text] [Related]  

  • 17. MRSA--too many hurdles to overcome: a study from Central India.
    Mallick SK; Basak S
    Trop Doct; 2010 Apr; 40(2):108-10. PubMed ID: 20305109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE) in a patient with Job's syndrome (hyperimmunoglobulin E syndrome) successfully treated with linezolid and high-dose daptomycin.
    Cunha BA; Krol V; Kodali V
    Heart Lung; 2008; 37(1):72-5. PubMed ID: 18206530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does resistance in severe infections caused by methicillin-resistant Staphylococcus aureus give you the 'creeps'?
    Brink AJ
    Curr Opin Crit Care; 2012 Oct; 18(5):451-9. PubMed ID: 22941206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial agents in treatment of MRSA infections.
    Johnson MD; Decker CF
    Dis Mon; 2008 Dec; 54(12):793-800. PubMed ID: 18996282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.